Theratechnologies Inc. Files Form 6-K: Key Regulatory Update Jan 2025

$THTX
Form 6-K
Filed on: 2025-01-10
Source
Theratechnologies Inc. Files Form 6-K: Key Regulatory Update Jan 2025

Here are the key insights and information extracted from the provided section of the financial report (Form 6-K) for Theratechnologies Inc.:

  1. Filing Type and Date:
  • This is a Form 6-K report filed by Theratechnologies Inc.
  • The report is dated January 10, 2025.
  1. Commission File Number:
  • The commission file number is 001-35203.
  1. Company Information:
  • Company Name: Theratechnologies Inc. (translated name).
  • Principal Executive Office Address:
    • 2015 Peel Street, Suite 1100,
    • Montréal, Québec, Canada H3A 1T8.
  1. Regulatory Compliance:
  • The registrant indicates that it is a foreign private issuer and it is filing this report under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
  1. Annual Report Filing:
  • The report asks if the registrant files or will file annual reports under Form 20-F or Form 40-F.
  • The response indicates filing under Form 20-F.
  1. Paper Submission:
  • The registrant is inquiring whether it is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) or (b)(7).
  • The form provides options for "Yes" or "No," indicating compliance with specific regulations.
  1. Press Release:
  • The document includes a reference to a press release dated January 9, 2025, which is likely relevant information that may contain important updates regarding the company’s performance or announcements.
  1. Signatures:
  • The report is signed by Jocelyn Lafond, who is the General Counsel and Corporate Secretary of Theratechnologies Inc.
  • The signature confirms the authenticity of the report as required by regulatory standards.

This report serves as a regulatory update to the SEC regarding Theratechnologies Inc., indicating compliance with necessary filing requirements, and providing essential company and filing details. Further insights would require analysis of the attached press release and any additional financial data.